Gambaran Umum
Johnson & Johnson, based in the United States, is a multinational corporation primarily engaged in the research, development, manufacture, and sale of a broad range of products in the healthcare sector. Predominantly recognized for its three major divisions: Pharmaceutical, Medical Devices, and Consumer Health, the company plays a pivotal role globally in areas ranging from prescription drugs and biotechnology to personal care and surgical products. Key projects that highlight its scope include the development of innovative pharmaceutical treatments for diseases such could include various cancer therapies, immunology, and the global distribution of its COVID-19 vaccine. Johnson & Johnson’s embrace of cutting-edge research and expansive product portfolio defines its prominent position in the healthcare industry.
Skor Kualitas, Nilai, dan Momentum
Kartu ini menunjukkan skor Kualitas, Nilai, dan Momentum untuk perusahaan tersebut.
Laporan Laba Rugi: Pendapatan, Laba Operasional, Laba Bersih
- Nilai revenue untuk Johnson & Johnson per 2025 Jun 29 adalah 90,627.00 MM.
- Nilai operating income untuk Johnson & Johnson per 2025 Jun 29 adalah 22,798.00 MM.
- Nilai net income untuk Johnson & Johnson per 2025 Jun 29 adalah 22,661.00 MM.
| Period End (TTM) | Revenue (MM) | Operating Income (MM) | Net Income (MM) |
| 2025-06-29 | 90,627.00 | 22,798.00 | 22,661.00 |
| 2025-03-30 | 89,331.00 | 22,729.00 | 21,810.00 |
| 2024-12-29 | 88,821.00 | 22,601.00 | 14,066.00 |
| 2024-09-29 | 87,696.00 | 23,149.00 | 14,684.00 |
| 2024-06-30 | 86,576.00 | 24,351.00 | 38,018.00 |
| 2024-03-31 | 85,648.00 | 23,775.00 | 38,476.00 |
| 2023-12-31 | 85,159.00 | 23,864.00 | 35,153.00 |
| 2023-10-01 | 83,703.00 | 24,127.00 | 34,624.00 |
| 2023-07-02 | 82,348.00 | 23,267.00 | 13,054.00 |
| 2023-04-02 | 77,458.00 | 21,852.00 | 12,724.00 |
| 2023-01-01 | 79,990.00 | 22,181.00 | 17,941.00 |
| 2022-10-02 | 84,855.00 | 22,141.00 | 19,157.00 |
| 2022-07-03 | 88,197.00 | 23,326.00 | 18,366.00 |
| 2022-04-03 | 94,880.00 | 25,035.00 | 19,830.00 |
| 2022-01-02 | 78,740.00 | 21,555.00 | 20,878.00 |
| 2021-10-03 | 91,446.00 | 24,338.00 | 17,880.00 |
| 2021-07-04 | 89,190.00 | 23,468.00 | 17,767.00 |
| 2021-04-04 | 84,214.00 | 21,224.00 | 15,115.00 |
| 2021-01-03 | 82,584.00 | 20,267.00 | 14,714.00 |
| 2020-09-27 | 80,856.00 | 20,057.00 | 16,986.00 |
| 2020-06-28 | |||
| 2020-03-29 |
Laporan Laba Rugi: EPS
| Period End (TTM) | Earnings Per Share Basic | Earnings Per Share Diluted |
| 2025-06-29 | ||
| 2025-03-30 | ||
| 2024-12-29 | 5.79 | |
| 2024-09-29 | 6.10 | 6.04 |
| 2024-06-30 | 15.60 | 15.45 |
| 2024-03-31 | 15.49 | 15.29 |
| 2023-12-31 | 13.88 | 13.72 |
| 2023-10-01 | 13.39 | 13.23 |
| 2023-07-02 | 5.00 | 4.93 |
| 2023-04-02 | 4.86 | 4.80 |
| 2023-01-01 | 6.83 | 6.73 |
| 2022-10-02 | 7.29 | 7.18 |
| 2022-07-03 | 6.98 | 6.87 |
| 2022-04-03 | 7.54 | 7.42 |
| 2022-01-02 | 7.93 | 7.81 |
| 2021-10-03 | 6.79 | 6.69 |
| 2021-07-04 | 6.75 | 6.65 |
| 2021-04-04 | 5.74 | 5.66 |
| 2021-01-03 | 5.59 | 5.51 |
| 2020-09-27 | 6.45 | 6.36 |
| 2020-06-28 | 5.77 | 5.68 |
| 2020-03-29 | 6.51 | 6.41 |
Arus Kas: Operasi, Investasi, Pendanaan
- Nilai cash from operating activities untuk Johnson & Johnson per 2025 Jun 29 adalah 23,028.00 MM.
- Nilai cash from investing activities untuk Johnson & Johnson per 2025 Jun 29 adalah -23,009.00 MM.
- Nilai kas dari aktivitas pendanaan untuk Johnson & Johnson per 2025 Jun 29 adalah -6,465.00 MM.
| Period End (TTM) | Cash From Operating Activities (MM) | Cash From Investing Activities (MM) | Cash From Financing Activities (MM) |
| 2025-06-29 | 23,028.00 | -23,009.00 | -6,465.00 |
| 2025-03-30 | 24,783.00 | -18,432.00 | 6,744.00 |
| 2024-12-29 | 24,266.00 | -18,599.00 | -3,132.00 |
| 2024-09-29 | 25,146.00 | -18,481.00 | -6,447.00 |
| 2024-06-30 | 24,642.00 | -12,812.00 | -7,882.00 |
| 2024-03-31 | 23,191.00 | -2,901.00 | -21,417.00 |
| 2023-12-31 | 22,791.00 | 878.00 | -15,825.00 |
| 2023-10-01 | 20,278.00 | -2,317.00 | -9,470.00 |
| 2023-07-02 | 19,073.00 | -6,559.00 | -2,078.00 |
| 2023-04-02 | 20,472.00 | -5,422.00 | 1,652.00 |
| 2023-01-01 | 21,194.00 | -12,371.00 | -8,871.00 |
| 2022-10-02 | 21,576.00 | -13,334.00 | -14,007.00 |
| 2022-07-03 | 23,582.00 | -14,352.00 | -12,289.00 |
| 2022-04-03 | 23,315.00 | -12,132.00 | -13,307.00 |
| 2022-01-02 | 23,410.00 | -8,683.00 | -14,047.00 |
| 2021-10-03 | 26,021.00 | -11,226.00 | -16,255.00 |
| 2021-07-04 | 26,114.00 | -13,326.00 | -9,852.00 |
| 2021-04-04 | 24,252.00 | -20,429.00 | -6,930.00 |
| 2021-01-03 | 23,536.00 | -20,825.00 | -6,120.00 |
| 2020-09-27 | 21,591.00 | -14,266.00 | -4,548.00 |
| 2020-06-28 | |||
| 2020-03-29 |
Metrik Penilaian: PE, PriceToBook, PriceToTBV
- P/Book
- The current closing price divided by the book value per share.
- P/TBV
- The current price divided by the tangible book value per share.
| Period End (TTM) | p/e | P/Book | P/TBV |
| 2025-06-29 | |||
| 2025-03-30 | |||
| 2024-12-29 | |||
| 2024-09-29 | |||
| 2024-06-30 | |||
| 2024-03-31 | |||
| 2023-12-31 | |||
| 2023-10-01 | |||
| 2023-07-02 | |||
| 2023-04-02 | |||
| 2023-01-01 | |||
| 2022-10-02 | |||
| 2022-07-03 | |||
| 2022-04-03 | |||
| 2022-01-02 | |||
| 2021-10-03 | |||
| 2021-07-04 | |||
| 2021-04-04 | |||
| 2021-01-03 | |||
| 2020-09-27 | |||
| 2020-06-28 | |||
| 2020-03-29 |
Metrik Penilaian: EBitToEv, EBit3YrAvgToEv
| Period End (TTM) | EBIT/EV | EBIT (3y)/EV |
| 2025-06-29 | ||
| 2025-03-30 | ||
| 2024-12-29 | ||
| 2024-09-29 | ||
| 2024-06-30 | ||
| 2024-03-31 | ||
| 2023-12-31 | ||
| 2023-10-01 | ||
| 2023-07-02 | ||
| 2023-04-02 | ||
| 2023-01-01 | ||
| 2022-10-02 | ||
| 2022-07-03 | ||
| 2022-04-03 | ||
| 2022-01-02 | ||
| 2021-10-03 | ||
| 2021-07-04 | ||
| 2021-04-04 | ||
| 2021-01-03 | ||
| 2020-09-27 | ||
| 2020-06-28 | ||
| 2020-03-29 |
Efektivitas Manajemen
- roa untuk Johnson & Johnson pada 2025 Jun 29 adalah 0.13.
- roe untuk Johnson & Johnson pada 2025 Jun 29 adalah 0.32.
- roic untuk Johnson & Johnson pada 2025 Jun 29 adalah 0.17.
- croic untuk Johnson & Johnson pada 2025 Jun 29 adalah 0.10.
- ocroic untuk Johnson & Johnson pada 2025 Jun 29 adalah 0.20.
| Period End (TTM) | ROA | ROE | ROIC (Tingkat Pengembalian Investasi Modal) | CROIC | OCROIC |
| 2025-06-29 | 0.13 | 0.32 | 0.17 | 0.10 | 0.20 |
| 2025-03-30 | 0.08 | 0.20 | 0.13 | 0.02 | 0.22 |
| 2024-12-29 | 0.09 | 0.19 | 0.14 | 0.00 | 0.23 |
| 2024-09-29 | 0.21 | 0.54 | 0.40 | -0.01 | 0.23 |
| 2024-06-30 | 0.21 | 0.53 | 0.39 | -0.01 | 0.22 |
| 2024-03-31 | 0.19 | 0.47 | 0.35 | 0.08 | 0.22 |
| 2023-12-31 | 0.20 | 0.45 | 0.33 | 0.08 | 0.19 |
| 2023-10-01 | 0.07 | 0.17 | 0.11 | 0.09 | 0.16 |
| 2023-07-02 | 0.07 | 0.17 | 0.10 | 0.13 | 0.16 |
| 2023-04-02 | 0.10 | 0.26 | 0.16 | -0.00 | 0.18 |
| 2023-01-01 | 0.11 | 0.28 | 0.18 | -0.06 | 0.20 |
| 2022-10-02 | 0.10 | 0.28 | 0.17 | -0.03 | 0.22 |
| 2022-07-03 | 0.11 | 0.30 | 0.18 | -0.02 | 0.21 |
| 2022-04-03 | 0.12 | 0.33 | 0.20 | 0.00 | 0.22 |
| 2022-01-02 | 0.10 | 0.28 | 0.17 | -0.01 | 0.25 |
| 2021-10-03 | 0.10 | 0.28 | 0.18 | 0.03 | 0.26 |
| 2021-07-04 | 0.10 | 0.24 | 0.15 | -0.03 | 0.24 |
| 2021-04-04 | 0.10 | 0.25 | 0.15 | -0.03 | 0.24 |
| 2021-01-03 | 0.11 | 0.29 | 0.17 | 0.03 | 0.21 |
| 2020-09-27 | 0.10 | 0.26 | 0.16 | -0.03 | 0.22 |
| 2020-06-28 | 0.11 | 0.29 | 0.19 | 0.01 | 0.26 |
| 2020-03-29 | 0.10 | 0.23 | 0.17 | -0.01 | 0.27 |
Gross Margins
- marjin kotor untuk Johnson & Johnson pada 2025 Jun 29 adalah 0.69.
- marjin bersih untuk Johnson & Johnson pada 2025 Jun 29 adalah 0.24.
- marjin operasi untuk Johnson & Johnson pada 2025 Jun 29 adalah 0.25.
- Margin Kotor
- The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.
- Margin Keuntungan Bersih
- Margin Bersih (juga dikenal sebagai Margin Keuntungan) adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Bersih. Perhitungannya adalah Pendapatan Bersih / Pendapatan.
- Margin Operasi
- Margin Operasi adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Operasi. Perhitungannya adalah Pendapatan Operasi / Pendapatan.
| Period End (TTM) | Margin Kotor | Margin Keuntungan Bersih | Margin Operasi |
| 2025-06-29 | 0.69 | 0.24 | 0.25 |
| 2025-03-30 | 0.69 | 0.16 | 0.24 |
| 2024-12-29 | 0.69 | 0.17 | 0.27 |
| 2024-09-29 | 0.69 | 0.47 | 0.28 |
| 2024-06-30 | 0.69 | 0.47 | 0.28 |
| 2024-03-31 | 0.69 | 0.41 | 0.26 |
| 2023-12-31 | 0.67 | 0.35 | 0.28 |
| 2023-10-01 | 0.67 | 0.13 | 0.27 |
| 2023-07-02 | 0.67 | 0.13 | 0.27 |
| 2023-04-02 | 0.68 | 0.19 | 0.27 |
| 2023-01-01 | 0.68 | 0.20 | 0.26 |
| 2022-10-02 | 0.68 | 0.19 | 0.26 |
| 2022-07-03 | 0.68 | 0.21 | 0.26 |
| 2022-04-03 | 0.68 | 0.22 | 0.26 |
| 2022-01-02 | 0.68 | 0.20 | 0.26 |
| 2021-10-03 | 0.67 | 0.20 | 0.26 |
| 2021-07-04 | 0.66 | 0.18 | 0.25 |
| 2021-04-04 | 0.66 | 0.18 | 0.25 |
| 2021-01-03 | 0.66 | 0.21 | 0.25 |
| 2020-09-27 | 0.66 | 0.19 | 0.25 |
| 2020-06-28 | 0.66 | 0.21 | 0.26 |
| 2020-03-29 | 0.67 | 0.18 | 0.26 |
Pengenal dan Deskriptor
| Kunci Indeks Pusat (CIK) | 200406 |
Grupong Pang-industriya
| SIC 2834 - Pharmaceutical Preparations |
